Page last updated: 2024-11-10

ix 207-887

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

IX 207-887: inhibits the release of IL-1alpha & beta from cultured murine macrophages or human mononuclear cells [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6509858
MeSH IDM0169304

Synonyms (8)

Synonym
acetic acid,2-(10-methoxy-4h-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)-
ix 207-887
XIKRQPKFOKKGGW-LCYFTJDESA-N
(z)-[10-methoxy-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene]-acetic acid
HY-106087
CS-0024821
ix207-887
AKOS040733476

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"A double-blind, controlled trial of 16 weeks' duration comparing placebo with IX at a daily dosage of 800 mg or 1,200 mg (20 patients/group) was conducted."( IX 207-887 in rheumatoid arthritis. A double-blind placebo-controlled study.
Amor, B; Beveridge, T; Bourdeix, I; Combe, B; Dougados, M; Lallemand, A; Sany, J, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (22.22%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (77.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]